Trial Design

INSIGHTS ON CLINICAL TRIAL DESIGN

Driving Engagement, Improving Outcomes: The Impact Of Virtual Registered Dietitian Support In Metabolic Trials
Traditional, decentralized, and hybrid trial models each offer unique benefits. The right approach can strengthen recruitment, retention, data quality, and study success.
Establishing Trust With Real People In Clinical Research
Get actionable strategies to enhance engagement, strengthen relationships, and support study success in clinical research through clear communication, transparency, and ethical practices.
Defining And Implementing The Right Oncology Digital Strategy
A panel of oncology experts shares how top life science companies are using a combination of DHTs, ePROs, clinical trial platforms, and more to ease oncology research and drastically reduce timelines.
Breaking The Trial Bottleneck: Smarter, Faster Paths To Patients
AI is speeding clinical trials — but silos and complexity persist. Discover how connected systems and automation can enable faster, more adaptive development.

ICH E6(R3): 10 FAQ On What Changed And What It Means For Your Trials
9/18/2025

The ICH E6(R3) updated guidelines present 10 critical changes to make clinical trials more efficient, adaptable, and patient-centric, while upholding the standards of scientific and ethical integrity.
How AI Is Reshaping Trial Design, Execution, And Disclosure
9/25/2025

AI has quietly embedded itself into the operational heart of clinical development, where it is accelerating decisions, reducing manual burden, and improving outcomes.
Dedicated Community Oncology Sites
7/29/2026

Rapid activation, strong referral partnerships, diverse patient access, and specialized immunotherapy infrastructure are reshaping oncology research.
Pay-By-Procedure Or Pay-By-Visit: Which Model Fits Your Trial?
5/28/2026

Site payment models shape trial cost and execution. Compare visit‑based simplicity vs procedure‑level precision to see when flexibility and savings beat complexity — or when predictability wins.
8 Critical Questions To Ask Your IRB
2/5/2025

This article outlines eight essential questions to ask a potential IRB partner to assess their ability to help you navigate complex regulatory requirements while avoiding delays.

Data Lifecycle At CRC

A structured data lifecycle from protocol design to database lock keeps trial data clean, compliant, and ready for regulatory submission.
Data-Driven Paths To Rare/Ultra-Rare Disease Therapy Approval

Explore how integrated regulatory, statistical, and operational expertise can be applied to help sponsors navigate complex development pathways and accelerate global approvals.
Post-Marketing Studies And Real-World Evidence Clinical Trials

Your trusted partner for decentralized post-marketing surveillance clinical trials and real-world evidence collection. Point-of-need accessibility. Proven compliance.
Central Nervous System Drug Development

CNS drug development faces unique hurdles — from high placebo response to complex protocols and recruitment challenges. Discover strategies to streamline trials, optimize planning, and accelerate delivery of innovative therapies for patients with critical unmet needs.
Ophthalmic Clinical Research Services

With over 40 clinical trials conducted in the area of ophthalmology, Altasciences combines depth of knowledge and expert capabilities to offer you a full range of early ophthalmic clinical development.